Literature DB >> 29251754

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]

Marco Valgimigli1, Héctor Bueno, Robert A Byrne, Jean-Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe Kolh, Laura Mauri, Gilles Montalescot, Franz-Josef Neumann, Mate Peticevic, Marco Roffi, Philippe Gabriel Steg, Stephan Windecker, Jose Luis Zamorano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29251754     DOI： 10.5603/KP.2017.0224

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  11 in total

1.  Effects of Aspirin Therapy on Bypass Efficacy and Survival of Patients Receiving Direct Cerebral Revascularization.

Authors:  Yanxiao Xiang; Ping Zhang; Peng Zhao; Tao Sun; Fei Wang; Yiming He; Donghai Wang; Anchang Liu
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

2.  YINGLONG: A Multicenter, Prospective, Non-Interventional Study Evaluating the Safety and Tolerability of Ticagrelor in Chinese Patients with Acute Coronary Syndrome.

Authors:  Xin Du; Yang Zheng; Ping Yang; Shuren Ma; Zaixin Yu; Xi Su; Junbo Ge; Maria Leonsson-Zachrisson; Xianhong Wang; Jing Sun; Lu Bai; Chang-Sheng Ma
Journal:  Adv Ther       Date:  2019-05-22       Impact factor: 3.845

Review 3.  Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?

Authors:  Charles E Howard; Vijay Nambi; Hani Jneid; Umair Khalid
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 5.501

4.  Bilateral multifocal muscular hemorrhage in the triceps surae during antiplatelet therapy: a case report.

Authors:  Young-In Go; Gi-Wook Kim
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

5.  P2Y12 Inhibitors Exacerbate Low-dose Aspirin-induced Small Bowel Injury in Dual Antiplatelet Therapy.

Authors:  Yukiko Handa; Shinya Fukushima; Motoyasu Osawa; Takahisa Murao; Osamu Handa; Hiroshi Matsumoto; Eiji Umegaki; Akiko Shiotani
Journal:  Intern Med       Date:  2021-11-15       Impact factor: 1.271

6.  Prior Antithrombotic Therapy is Associated with Increased Risk of Death in Patients with Intracerebral Hemorrhage: Findings from the Chinese Stroke Center Alliance (CSCA) Study.

Authors:  Dacheng Liu; Hongqiu Gu; Yuehua Pu; Jingyi Liu; Kaixuan Yang; Wanying Duan; Xin Liu; Ximing Nie; Zhe Zhang; Chunjuan Wang; Xingquan Zhao; Yilong Wang; Zixiao Li; Liping Liu
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

7.  Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.

Authors:  Elvin Kedhi; Enrico Fabris; Martin van der Ent; Pawel Buszman; Clemens von Birgelen; Vincent Roolvink; Alexander Zurakowski; Carl E Schotborgh; Jan C A Hoorntje; Christian Hasbø Eek; Stéphane Cook; Marco Togni; Martijn Meuwissen; Niels van Royen; Ria van Vliet; Hans Wedel; Ronak Delewi; Felix Zijlstra
Journal:  BMJ       Date:  2018-10-02

Review 8.  The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and "Asian Paradox".

Authors:  Jeehoon Kang; Hyo Soo Kim
Journal:  Korean Circ J       Date:  2018-07       Impact factor: 3.243

9.  Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

Authors:  Ziad Hijazi; Jonas Oldgren; Johan Lindbäck; John H Alexander; Marco Alings; Raffaele De Caterina; John W Eikelboom; Michael D Ezekowitz; Claes Held; Kurt Huber; Elaine M Hylek; Christopher B Granger; Renato D Lopes; Dragos Vinereanu; Agneta Siegbahn; Lars Wallentin
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  Hybrid rotablation and drug-eluting balloon strategy.

Authors:  Ahmed Vachiat; Mpiko Ntsekhe; Farrel Hellig
Journal:  Cardiovasc J Afr       Date:  2020-11-12       Impact factor: 1.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.